View this email in your browser
UBC-led research team receives over $40 million for Advanced Therapeutics Manufacturing Facility
![](https://usend.ubc.ca/sendy/uploads/1717193149.jpg)
The Advanced Therapeutics Manufacturing Facility (ATMF) on UBC’s Vancouver campus will be a cornerstone of Canada’s life sciences ecosystem, enabling researchers and biotech start-ups to turn their discoveries into patient-ready treatments for Canadians.
Link to full story
MS Research Network timeline
As this is our inaugural newsletter, we invite you to learn more about the MS Research Network. Take a look at our timeline of milestones so far.
Funding opportunities
All opportunities
Events
- Dr. Donald Paty Lectureship with Dr. Amit Bar-Or,"Tackling Heterogeneity in Multiple Sclerosis: on Path to Precision Neuroimmunology," Jim Pattison Pavilion Room 1891 Paetzold Atrium & Lecture Theatre, Vancouver General Hospital or Zoom, June 19, 9:00–10:00 a.m.
- Federation of Clinical Immunology Societies, San Francisco, USA, June 18–21
- The International Society for Stem Cell Research, Hamburg, Germany, July 10–13
All events
Innovator spotlight
![](https://usend.ubc.ca/sendy/uploads/1717193328.jpg)
Dr. Harold Atkins is a senior clinician investigator of the Cancer Therapeutics Program with Ottawa Hospital Research Institute, physician with the Transplant and Cell Therapy Program at the Ottawa Hospital. He pioneered the use of hematopoietic stem cell transplantation (HSCT) for immune system repair in autoimmune diseases such as multiple sclerosis, myasthenia gravis, and stiff person syndrome...
Read full story
Careers
Feedback
We invite you to complete a brief survey to share your thoughts as members of our growing community. Your feedback will be invaluable in shaping the readership experience and future content of the The Signal.
Survey link
FAST FACTS
|
|
|